Skip to content
Biohaven Ltd icon

Biohaven Ltd

BHVNStocksPharmaceuticals MajorUnited StatesNYSEUSD

Price

$14.86

Today

+4.5%

YTD

+31.9%

About

Biohaven Ltd is headquartered in the British Virgin Islands and the US. It’s a biopharmaceutical company dedicated to developing innovative treatments in key therapeutic areas such as neuroscience, immunology and oncology. Its primary aim is to discover and advance new treatments for patients facing significant unmet medical needs globally. Operating within the healthcare sector, Biohaven Ltd is advancing a diverse pipeline of potential treatments across various therapeutic modalities. It is advancing many late and early-stage drug development programs. Stay up to date on the share price of BHVN by adding it to your eToro watchlist This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.

Price chart
Closing price history for BHVN (1D candles).
Open positions
Current open positions for this instrument from your live portfolio.

Open positions

0

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-2.79
P/S (TTM)0.00
P/B (TTM)18.40
Market cap$2.38B
Cap tierMid-cap
Industry avg P/E-43.27

Profitability

Gross marginUnknown
EBIT margin0.00%
Net marginUnknown
ROE-333.00%
ROA-139.99%

Earnings & Revenue

Revenue (TTM)$0.00
Revenue growth (1Y)Unknown
EPS (TTM)-$5.67
Free cash flow$-594.49M
Total debt$286.18M

Dividends & Risk

Dividend rate$0.00
Dividend yield0.00%
Beta (5Y)1.59
Employees274
Next earnings9 Nov '26
Trade history

Closed trades

0

Realized return

+0.0%

No stored closed trades exist for this instrument yet.

Biohaven Ltd (BHVN) | Dirk Kuyken